Curated News
By: NewsRamp Editorial Staff
November 19, 2024
Lorati Introduces Breakthrough AMD Treatment with Nano-Grade Eye Drops
Discuss on Reddit
LinkedIn
Substack
TelegramTLDR
- Lorati's nano-grade eye drops have successfully reversed AMD, giving a competitive advantage in treating both dry and wet forms of the disease.
- The nano-grade eye drops work by clearing drusen and lipofuscin while regenerating photoreceptor cells to reverse AMD.
- Lorati's breakthrough in AMD treatment has transformed the lives of dozens of patients, making the world a better place for those suffering from vision loss.
- Nano-grade eye drops based on montmorillonite are a fascinating and effective treatment for AMD, offering hope to those affected by the disease.
Impact - Why it Matters
This news matters as it represents a significant advancement in the treatment of age-related macular degeneration, potentially offering hope to those suffering from this condition. The new treatment has the potential to transform the lives of AMD patients, restoring vision and improving their quality of life.
Summary
Lorati Company Limited has introduced a groundbreaking advancement in the treatment of age-related macular degeneration (AMD) with its nano-grade eye drops. CEO David Lo announced that these eye drops have successfully reversed AMD in numerous patients, including those previously deemed legally blind due to conditions such as drusenoid PED. The nano-grade eye drops are designed to simultaneously clear drusen and lipofuscin while regenerating photoreceptor cells—crucial steps in reversing AMD.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, Lorati Introduces Breakthrough AMD Treatment with Nano-Grade Eye Drops
